Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis

BACKGROUND: The efficacy and safety of combination therapy with adalimumab (ADA) plus intensive granulocyte and monocyte adsorptive apheresis (GMA) (two sessions per week) for the treatment of refractory ulcerative colitis (UC) have not been previously evaluated. METHODS: This retrospective study ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanida, Satoshi, Mizoshita, Tsutomu, Nishie, Hirotada, Ozeki, Keiji, Katano, Takahito, Kubota, Eiji, Kataoka, Hiromi, Kamiya, Takeshi, Joh, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596271/
https://www.ncbi.nlm.nih.gov/pubmed/26491502
http://dx.doi.org/10.14740/jocmr2333w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596271/
https://www.ncbi.nlm.nih.gov/pubmed/26491502
http://dx.doi.org/10.14740/jocmr2333w

Ejemplares similares